+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Medical Information - Global Strategic Business Report

  • PDF Icon

    Report

  • 270 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6018308
The global market for Medical Information was estimated at US$2.8 Billion in 2023 and is projected to reach US$4.1 Billion by 2030, growing at a CAGR of 5.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Medical Information Market - Key Trends and Drivers Summarized

How Has Medical Information Evolved Over Time?

Medical information has undergone a dramatic transformation over the last few decades, evolving from paper-based records maintained in filing cabinets to sophisticated electronic health records (EHRs) that can be accessed in real-time from anywhere in the world. In the past, the sharing of patient data between healthcare providers was often slow and inefficient, leading to fragmented care. However, with the advent of digital solutions, medical information is now more streamlined and accessible, enhancing the overall quality of healthcare. This shift has been driven by the increasing demand for better patient outcomes, data security, and regulatory compliance. In addition, healthcare providers and patients alike are now embracing mobile health (mHealth) applications, wearables, and telemedicine to monitor and manage health conditions remotely. These advancements have resulted in more personalized care, with data playing a crucial role in tailoring treatments to individual patients' needs, thus moving the medical landscape toward more proactive and preventive care approaches. This evolution highlights how crucial technology has become in bridging the gap between patients and healthcare providers.

What Are the Ethical and Privacy Challenges Facing Medical Information Today?

Despite the undeniable benefits of digital medical information, significant concerns about data privacy and security persist. The rise of cyber-attacks and data breaches has left both patients and healthcare providers vulnerable to the potential misuse of sensitive medical information. One of the most pressing ethical issues involves the balance between data sharing and patient confidentiality. As more data is shared across networks to facilitate collaborative care and research, there is a growing need to ensure that patient consent is properly obtained, and their data remains secure. Regulatory frameworks, such as the Health Insurance Portability and Accountability Act (HIPAA) in the U.S. and the General Data Protection Regulation (GDPR) in Europe, have set strict guidelines on how medical data should be handled. However, these regulations vary significantly across regions, making it difficult to create a global standard for medical information security. Additionally, the use of artificial intelligence (AI) and machine learning algorithms to analyze medical data has sparked debates about potential biases in decision-making and the transparency of these systems. As technology continues to evolve, addressing these ethical and privacy challenges will be paramount to maintaining trust in the healthcare system.

What Role Does Technology Play in Transforming Access to Medical Information?

Technology is at the forefront of revolutionizing how medical information is accessed, shared, and utilized. The rise of big data analytics has enabled healthcare providers to analyze vast amounts of medical data to detect patterns and predict health outcomes, thus improving the overall efficiency of the healthcare system. The integration of cloud computing has further enabled healthcare organizations to store and access medical records securely while reducing the costs associated with on-premise storage systems. Furthermore, telemedicine platforms and patient portals have empowered patients to take more control of their health, allowing them to access their medical records, communicate with their healthcare providers, and even schedule appointments online. The use of AI in diagnostic tools is also enhancing the accuracy and speed of diagnosis, reducing the chances of human error and enabling healthcare providers to make more informed decisions. Wearable devices, such as smartwatches and fitness trackers, are allowing for continuous monitoring of patients' vital signs, leading to early detection of health issues and more timely interventions. As the healthcare system continues to digitize, technology will undoubtedly play an even greater role in improving both the accessibility and quality of medical information.

What Are the Growth Drivers in the Medical Information Market?

The growth in the medical information market is driven by several factors, many of which are directly linked to technological advancements and changing consumer behavior. First, the increasing adoption of EHR systems across healthcare facilities worldwide has created a massive demand for reliable and scalable digital solutions. The need for interoperability between different systems is another key driver, as healthcare providers seek seamless ways to share patient information across multiple platforms and institutions. Additionally, the growing prevalence of chronic diseases has necessitated more frequent and comprehensive patient monitoring, leading to a surge in demand for remote monitoring devices and mHealth applications. Consumer behavior has also shifted, with patients increasingly expecting more convenient, digital-first healthcare experiences. This has driven the rapid growth of telemedicine services. Government initiatives promoting digital health and the need for data-driven decision-making in healthcare are also contributing to the expansion of the market. Lastly, the integration of AI and machine learning into medical information systems is enhancing predictive analytics and diagnostic accuracy, further fueling market growth by providing healthcare providers with cutting-edge tools to manage patient data more effectively.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the In-House Services segment, which is expected to reach US$2.3 Billion by 2030 with a CAGR of a 5.0%. The Contract Outsourcing Services segment is also set to grow at 5.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $766.6 Million in 2023, and China, forecasted to grow at an impressive 8.6% CAGR to reach $843.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Medical Information Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Medical Information Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Medical Information Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Medical Information market such as Accenture Plc, Cognizant Technology Solutions U.S. Corporation, Eversana, Groupe ProductLife S.A.S., Infosys Ltd. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 36 companies featured in this Medical Information market report include:

  • Accenture Plc
  • Cognizant Technology Solutions U.S. Corporation
  • Eversana
  • Groupe ProductLife S.A.S.
  • Infosys Ltd.
  • Inizio Engage
  • Intellectsoft
  • IQVIA, Inc.
  • McKesson Corporation
  • Med Communications

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Medical Information - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Accurate and Timely Healthcare Data Propels Growth in the Medical Information Market
  • Increasing Focus on Patient-Centered Care Expands Addressable Market for Personalized Medical Information Solutions
  • Technological Advancements in Electronic Health Records (EHR) Drive Innovation in Medical Information Systems
  • Growing Use of AI and Machine Learning in Data Analysis Strengthens the Business Case for Medical Information Management
  • Rising Adoption of Telemedicine and Digital Health Platforms Spurs Demand for Real-Time Medical Information Access
  • Increasing Use of Mobile Health (mHealth) Apps Propels Growth in Consumer Access to Medical Information
  • Innovations in Blockchain for Secure Data Sharing Drive Trust in Medical Information Platforms
  • Here`s How the Expansion of Health Information Exchanges (HIEs) Accelerates the Interoperability of Medical Information Systems
  • Surging Demand for Clinical Decision Support Systems (CDSS) Drives Growth in Medical Information Integration
  • Advancements in Wearable Devices and IoT Propel Growth in the Real-Time Medical Information Market
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Medical Information Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Medical Information by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Medical Information by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for In-House Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for In-House Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for In-House Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Contract Outsourcing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Contract Outsourcing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Contract Outsourcing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Pharmaceuticals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Medical Device Manufacturers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Medical Device Manufacturers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Medical Device Manufacturers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Biotechnology Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 20: USA Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 21: USA Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: USA 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 23: USA Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
CANADA
  • Table 26: Canada Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: Canada Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: Canada 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 29: Canada Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: Canada 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
JAPAN
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 32: Japan Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Japan Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Japan 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 35: Japan Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Japan 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
CHINA
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 38: China Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: China Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: China 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 41: China Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: China Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: China 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
EUROPE
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 44: Europe Recent Past, Current & Future Analysis for Medical Information by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 45: Europe Historic Review for Medical Information by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: Europe 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 47: Europe Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
FRANCE
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 53: France Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: France Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: France 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 56: France Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: France Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: France 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
GERMANY
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 59: Germany Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: Germany Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: Germany 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 62: Germany Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Germany 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
ITALY
  • Table 65: Italy Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Italy Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Italy 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 68: Italy Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: Italy 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 71: UK Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: UK Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: UK 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 74: UK Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: UK Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: UK 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
SPAIN
  • Table 77: Spain Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: Spain Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: Spain 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 80: Spain Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: Spain 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
RUSSIA
  • Table 83: Russia Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: Russia Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Russia 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 86: Russia Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Russia 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: Rest of Europe Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Rest of Europe 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 96: Asia-Pacific Historic Review for Medical Information by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 97: Asia-Pacific 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
AUSTRALIA
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Accenture Plc
  • Cognizant Technology Solutions U.S. Corporation
  • Eversana
  • Groupe ProductLife S.A.S.
  • Infosys Ltd.
  • Inizio Engage
  • Intellectsoft
  • IQVIA, Inc.
  • McKesson Corporation
  • Med Communications

Table Information